Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus

被引:36
作者
Shindoh, Junichi [1 ]
Hasegawa, Kiyoshi [1 ]
Matsuyama, Yutaka [1 ]
Inoue, Yosuke [1 ]
Ishizawa, Takeaki [1 ]
Aoki, Taku [1 ]
Sakamoto, Yoshihiro [1 ]
Sugawara, Yasuhiko [1 ]
Makuuchi, Masatoshi [2 ]
Kokudo, Norihiro [1 ]
机构
[1] Univ Tokyo, Tokyo 1138655, Japan
[2] Japan Red Cross Med Ctr, Tokyo, Japan
关键词
INTERFERON THERAPY; POSTOPERATIVE RECURRENCE; INTRAHEPATIC RECURRENCE; LIVER RESECTION; RISK-FACTORS; CIRRHOSIS; SURVIVAL; ABLATION; SURGERY; METAANALYSIS;
D O I
10.1200/JCO.2012.44.3234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Hepatitis C virus (HCV) infection has been recognized as a potent risk factor for the postoperative recurrence of hepatocellular carcinoma (HCC). However, little is known about the impact of HCV viral load on surgical outcomes. The study objective was to investigate clinical significance of HCV viral load on long-term outcomes of HCC. Patients and Methods Three hundred seventy patients who were classified as Child-Pugh class A and underwent curative liver resections for HCV-related HCC were divided into low and high viral load groups (<= or >5.3 log(10)IU/mL) based on the results of a minimum P value approach to predict moderate to severe activity of hepatitis; the clinical outcomes were then compared. Results The 5-year recurrence-free survival rate was 36.1% in the low viral load group and 12.4% in the high viral load group (P < .001). The 5-year overall survival rate was 76.6% in the low viral load group and 57.7% in the high viral load group (P < .001). Multivariate analysis confirmed significant correlation between high viral load and tumor recurrence with a hazard ratio of 1.87 (95% CI, 1.41 to 2.48; P < .001). Subanalysis revealed that the favorable results in the low viral load group were not attributed to whether or not serologic eradication of HCV was obtained both in primary and recurrent lesions. Conclusion Low HCV viral load predicts better long-term surgical outcomes in patients with HCC regardless of the serologic eradication of HCV. J Clin Oncol 31:766-773. (C) 2012 by American Society of Clinical Oncology
引用
收藏
页码:766 / 773
页数:8
相关论文
共 52 条
[1]   Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma [J].
Akamatsu, M ;
Yoshida, H ;
Shiina, S ;
Teratani, T ;
Tateishi, R ;
Obi, S ;
Sato, S ;
Koike, Y ;
Fujishima, T ;
Ishikawa, T ;
Shiratori, Y ;
Omata, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (05) :459-466
[2]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[3]   Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid [J].
Combes, B ;
Carithers, RL ;
Maddrey, WC ;
Munoz, S ;
Garcia-Tsao, G ;
Bonner, GF ;
Boyer, JL ;
Luketic, VA ;
Shiffman, ML ;
Peters, MG ;
White, H ;
Zetterman, RK ;
Risser, R ;
Rossi, SS ;
Hofmann, AF .
HEPATOLOGY, 1999, 29 (06) :1649-1654
[4]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[5]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[6]  
2-E
[7]   Hepatectomy for hepatocellular carcinoma -: The surgeon's role in long-term survival [J].
Fan, ST ;
Ng, IOL ;
Poon, RTP ;
Lo, CM ;
Liu, CL ;
Wong, J .
ARCHIVES OF SURGERY, 1999, 134 (10) :1124-1130
[8]   Hepatocellular carcinoma and cirrhosis - Results of surgical treatment in a European series [J].
Fuster, J ;
GarciaValdecasas, JC ;
Grande, L ;
Tabet, J ;
Bruix, J ;
Anglada, T ;
Taura, P ;
Lacy, AM ;
Gonzalez, X ;
Vilana, R ;
Bru, C ;
Sole, M ;
Visa, J .
ANNALS OF SURGERY, 1996, 223 (03) :297-302
[9]   Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value [J].
Grazi, GL ;
Ercolani, G ;
Pierangeli, F ;
Del Gaudio, M ;
Cescon, M ;
Cavallari, A ;
Mazziotti, A .
ANNALS OF SURGERY, 2001, 234 (01) :71-78
[10]   Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].
Hadziyannis, SJ ;
Sette, H ;
Morgan, TR ;
Balan, V ;
Diago, M ;
Marcellin, P ;
Ramadori, G ;
Bodenheimer, H ;
Bernstein, D ;
Rizzetto, M ;
Zeuzem, S ;
Pockros, PJ ;
Lin, A ;
Ackrill, AM .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355